|
|
Blood, 1 February 2004, Vol. 103, No. 3, pp. 1043-1049.
Prepublished online as a Blood First Edition Paper on October 2, 2003; DOI 10.1182/blood-2003-05-1518.
Previous Article | Table of Contents | Next Article 
NEOPLASIA
Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia
Bernard M. Fine,
Martin Stanulla,
Martin Schrappe,
Minh Ho,
Susanne Viehmann,
Jochen Harbott, and
Linda M. Boxer
From the Center for Molecular Biology in Medicine, VA Palo Alto Health Care System, Palo Alto, CA, and Department of Medicine, Stanford University School of Medicine, Palo Alto, CA; Department of Biochemistry and Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA; Department of Pediatric Hematology and Oncology, Medizinische Hochschule Hannover, Hannover, Germany; and the Oncogenetic Laboratory, Children's University Hospital, Giessen, Germany.
We obtained a global view of gene expression in both cell lines and pediatric acute lymphoblastic leukemia (ALL) samples that harbor one of several selected chromosomal abnormalities. When the cell lines were studied alone, we found that these chromosomal abnormalities were associated with the predominant variation in transcriptional programs across the set of cell lines studied. When cell lines and clinical samples were studied together, we found that each chromosomal abnormality (TEL/AML1, BCR/ABL, or MLL abnormalities) was associated with a characteristic gene expression signature that was shared by both cell lines and clinical samples. However, BCR/ABL was associated with a much more heterogeneous pattern of expression than were TEL/AML1 and MLL abnormalities. This observation has important implications for the study of BCR/ABL ALL. In addition, we systematically identified genes whose expression was associated with TEL/AML1, BCR/ABL, or MLL abnormalities in both clinical samples and cell lines. Although some of these genes have previously been described, many have not previously been reported to be associated with one of these chromosomal abnormalities. Notably, we found that the erythropoietin receptor (EPOR) is consistently highly expressed in TEL/AML1 ALL compared with BCR/ABL or MLL. (Blood. 2004;103:1043-1049)

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Argiropoulos, E. Yung, and R. K. Humphries
Unraveling the crucial roles of Meis1 in leukemogenesis and normal hematopoiesis
Genes & Dev.,
November 15, 2007;
21(22):
2845 - 2849.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Cario, S. Izraeli, A. Teichert, P. Rhein, J. Skokowa, A. Moricke, M. Zimmermann, A. Schrauder, L. Karawajew, W.-D. Ludwig, et al.
High Interleukin-15 Expression Characterizes Childhood Acute Lymphoblastic Leukemia With Involvement of the CNS
J. Clin. Oncol.,
October 20, 2007;
25(30):
4813 - 4820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Akasaka, T. Balasas, L. J. Russell, K.-j. Sugimoto, A. Majid, R. Walewska, E. L. Karran, D. G. Brown, K. Cain, L. Harder, et al.
Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)
Blood,
April 15, 2007;
109(8):
3451 - 3461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Juric, N. J. Lacayo, M. C. Ramsey, J. Racevskis, P. H. Wiernik, J. M. Rowe, A. H. Goldstone, P. J. O'Dwyer, E. Paietta, and B. I. Sikic
Differential Gene Expression Patterns and Interaction Networks in BCR-ABL-Positive and -Negative Adult Acute Lymphoblastic Leukemias
J. Clin. Oncol.,
April 10, 2007;
25(11):
1341 - 1349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Tamayo, D. Scanfeld, B. L. Ebert, M. A. Gillette, C. W. M. Roberts, and J. P. Mesirov
Metagene projection for cross-platform, cross-species characterization of global transcriptional states
PNAS,
April 3, 2007;
104(14):
5959 - 5964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Starkova, J. Madzo, G. Cario, T. Kalina, A. Ford, M. Zaliova, O. Hrusak, and J. Trka
The Identification of (ETV6)/RUNX1-Regulated Genes in Lymphopoiesis Using Histone Deacetylase Inhibitors in ETV6/RUNX1-Positive Lymphoid Leukemic Cells
Clin. Cancer Res.,
March 15, 2007;
13(6):
1726 - 1735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Roman-Gomez, A. Jimenez-Velasco, X. Agirre, J. A. Castillejo, G. Navarro, M. J. Calasanz, L. Garate, E. San Jose-Eneriz, L. Cordeu, F. Prosper, et al.
CpG Island Methylator Phenotype Redefines the Prognostic Effect of t(12;21) in Childhood Acute Lymphoblastic Leukemia.
Clin. Cancer Res.,
August 15, 2006;
12(16):
4845 - 4850.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kirschner-Schwabe, C. Lottaz, J. Todling, P. Rhein, L. Karawajew, C. Eckert, A. von Stackelberg, U. Ungethum, D. Kostka, A. E. Kulozik, et al.
Expression of Late Cell Cycle Genes and an Increased Proliferative Capacity Characterize Very Early Relapse of Childhood Acute Lymphoblastic Leukemia
Clin. Cancer Res.,
August 1, 2006;
12(15):
4553 - 4561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Hess, C. B. Bittner, D. T. Zeisig, C. Bach, U. Fuchs, A. Borkhardt, J. Frampton, and R. K. Slany
c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells
Blood,
July 1, 2006;
108(1):
297 - 304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Aldrich, L. Zhang, J. L. Wiemels, X. Ma, M. L. Loh, C. Metayer, S. Selvin, J. Feusner, M. T. Smith, and P. A. Buffler
Cytogenetics of Hispanic and white children with acute lymphoblastic leukemia in california.
Cancer Epidemiol. Biomarkers Prev.,
March 1, 2006;
15(3):
578 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Pui and W. E. Evans
Treatment of Acute Lymphoblastic Leukemia
N. Engl. J. Med.,
January 12, 2006;
354(2):
166 - 178.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chiaretti, X. Li, R. Gentleman, A. Vitale, K. S. Wang, F. Mandelli, R. Foa, and J. Ritz
Gene Expression Profiles of B-lineage Adult Acute Lymphocytic Leukemia Reveal Genetic Patterns that Identify Lineage Derivation and Distinct Mechanisms of Transformation
Clin. Cancer Res.,
October 15, 2005;
11(20):
7209 - 7219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. French, M. R. Wilkinson, W. Yang, L. de Chaisemartin, E. H. Cook, S. Das, M. J. Ratain, W. E. Evans, J. R. Downing, C.-H. Pui, et al.
Global gene expression as a function of germline genetic variation
Hum. Mol. Genet.,
June 15, 2005;
14(12):
1621 - 1629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Cario, M. Stanulla, B. M. Fine, O. Teuffel, N. v. Neuhoff, A. Schrauder, T. Flohr, B. W. Schafer, C. R. Bartram, K. Welte, et al.
Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia
Blood,
January 15, 2005;
105(2):
821 - 826.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Fine, G. J.L. Kaspers, M. Ho, A. H. Loonen, and L. M. Boxer
A Genome-Wide View of the In vitro Response to L-Asparaginase in Acute Lymphoblastic Leukemia
Cancer Res.,
January 1, 2005;
65(1):
291 - 299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Pui, M. Schrappe, R. C. Ribeiro, and C. M. Niemeyer
Childhood and Adolescent Lymphoid and Myeloid Leukemia
Hematology,
January 1, 2004;
2004(1):
118 - 145.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|